IDT and Beckman Coulter Life Sciences' collaboration marks a significant step forward in enabling labs to streamline oncology research workflows with enhanced precision, scalability, and ...

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...

Request To Download Free Sample of This Strategic Report @ Market Overview: The global immuno-oncology assay market was valued at $2,769.50 million in 2018, and it is projected to reach $6,179.20 ...

Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the ...

Diagnosed with small-cell lung cancer at 28, Montessa Lee has defied the odds for nearly 20 years, surviving a disease with a ...

Market Landscape The Asia Pacific oncology molecular diagnostics market is characterized by a diverse landscape, encompassing various technologies and applications tailored to the region’s unique ...

Maida Mangiameli, 75, has defied the odds by surviving over seven years with small-cell lung cancer—a disease with a ...

Cancer charities also in attendance at the session, entitled ‘Closing the Gap: Bringing Cancer Genomic Testing to Scottish ...

This sort of play is once again a common occurrence for Hufanga, the 2022 All-Pro who battled injuries the past two years ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced it will be presenting new data ...

Although innovations in cancer care are rapidly emerging, systemic and social barriers continue to challenge the delivery of optimal care. The intersection of cutting-edge oncology treatment with ...